drugset / Trial / NCT05039411

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease

NCT05039411 ↗

Phase 1 Recruiting 5 enrolled CryoCord Sdn Bhd University of Malaya · collab
NaSingle-groupOpen-labelTreatment

Summary

Objectives: Primary: To demonstrate the safety of allogeneic UC-MSCs administered by injection for complex perianal fistulas in patients with Crohn's disease Secondary: To determine the efficacy of a single/multiple allogeneic UC-MSCs injection in improving complex perianal fistula complications and (re-epithelialization of the external openings).

Timeline

Start
2022-03-01
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject PF2020-CELL Cell therapy 60 cells Other